YTTRIGA Radiopharmaceutical precursor, solution Ref.[11010] Active ingredients: Yttrium ⁹⁰Y chloride

Source: European Medicines Agency (EU)  Revision Year: 2021  Publisher: Eckert & Ziegler Radiopharma GmbH, Robert-Rössle-Str. 10, D-13125 Berlin, Germany

Product name and form

Yttriga radiopharmaceutical precursor, solution.

Pharmaceutical Form

Radiopharmaceutical precursor, solution.

Clear colourless solution, free of particulate matter.

Qualitative and quantitative composition

1 ml sterile solution contains 0.1-300 GBq Yttrium (90Y) on the reference date and time (corresponding to 0.005-15 micrograms of Yttrium [90Y]) (as Yttrium [90Y] chloride).

Each 3ml vial contains 0.1-300 GBq, corresponding to 0.005-15 micrograms of Yttrium (90Y), at reference date and time. The volume is 0.02-3 ml.

Each 10ml vial contains 0.1-300 GBq, corresponding to 0.005-15 micrograms of Yttrium (90Y), at reference date and time. The volume is 0.02-5 ml.

The theoretical specific activity is 20 GBq/microgram of Yttrium (90Y) (see section 6.5).

Yttrium (90Y) chloride is produced by decay of its radioactive precursor Strontium ( 90Sr). It decays by emission of beta radiation of 2.281 MeV (99.98 %) of maximal energy to stable Zirconium ( 90Zr).

Yttrium (90Y) has a half-life of 2.67 days (64.1 hours).

Active Ingredient Description
Yttrium ⁹⁰Y chloride

Yttrium (90Y) chloride is produced by decay of its radioactive precursor Strontium (90Sr). It decays by emission of beta radiation of 2.281 MeV (99.98 %) of maximal energy to stable zirconium (90Zr). 90Y-yttrium has a half-life of 2.67 days (64.1 hours).

List of Excipients

Hydrochloric acid (0.04 M)

Pack sizes and marketing

Colourless type I glass vial of 3 ml with a V-shapped bottom or a colourless type I glass vial of 10 ml with a flat bottom with a silicon stopper, closed with an aluminium seal.

Pack size: 1 vial.

Not all presentations may be marketed.

Marketing authorization holder

Eckert & Ziegler Radiopharma GmbH, Robert-Rössle-Str. 10, D-13125 Berlin, Germany

Marketing authorization dates and numbers

EU/1/05/322/001 (3 ml V-shaped vial)

EU/1/05/322/002 (10 ml flat bottom vial)

Date of first authorisation: 19/01/2006

Date of renewal: 06/01/2011

Drugs

Drug Countries
YTTRIGA Austria, Estonia, Spain, France, Ireland, Lithuania, Poland, Romania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.